Pharma Social Media Strategy Guidebook - by Telerx

Social media presents new opportunities for patients to manage their health – empowering them to seek direct access to information about medical conditions, treatment options and patient communities. Are you prepared to support them?

Download the guidebook today to uncover a best practice approach to social participation and strategy development.

http://www.pharmalinx.com/Telerx_PharmaSocialMedia/

Overview:

The increased adoption of social media is impacting every industry, but maybe none more than the healthcare industry. Patients and healthcare providers (HCPs) are looking to social media for information and support regarding their health and the health of their patients. Social media offers you an opportunity to interact with patients, caregivers and HCPs on topics for which you have unique and valuable insights. These interactions can improve outcomes, open new opportunities, and increase loyalty.

What is this new Patch Pump? Webinar Dec 2

Subcutaneous Delivery by Patch Pump – A New Route for Proven Parenterals

Tuesday – December 2, 2014 / 01:00 pm EST/10am PT – Free Attendance

Register now
http://bit.ly/sc-webinar

Certificate of Attendance provided on request

Traditional delivery of parenteral drugs comes with an associated burden of cost, discomfort and inconvenience. Through the conversion of iv therapy to subcutaneous drug administration, made possible by novel patch pump technology, a new paradigm of "anytime, anywhere" drug delivery, has emerged. Drs. Muntendam, Pitt and Nguyen will introduce the enabling technology and the opportunities it presents to improve heart failure outcomes and outpatient parenteral antibiotic therapy (OPAT) treatment alternatives.

Key Take Aways:

• Unique pump technology enables convenient and comfortable subcutaneous administration of parenteral drug by patient or caregiver.
• Anytime, anywhere administration of parenteral drugs improves medical outcomes and reduces the burden to patient and payor.
• Subcutaneous delivery of furosemide introduces new heart failure treatment options that reduce the reliance on inpatient and emergency room care.
• Subcutaneous delivery of antibiotics enables effective antibiotic therapy without the need of PICC lines or infusion services.

Who Should Attend:

Managers and above in...

• Infectious disease drug research and development
• Cardiovascular drug and device research and development
• Business development
• Strategy
• Medical Directors of health plans, hospitals, accountable care organizations, large family practices
• Pharma Directors

OnDemand Webinar: Handling Missing Data in Analgesic Clinical Trials

Handling Missing Data in Analgesic Clinical Trials; Dropouts, Regulatory Strategies and Practical Implications

View the recorded webinar today

Speaker: Neil Singla, MD, Owner, Managing Member, Lotus Clinical Research

When it comes to subject dropouts, an ounce of prevention is worth a pound of cure. Subject and study staff education can reduce dropout rates. The lecture will focus on educational paradigms designed to reduce dropouts and their efficacy. Regardless of technique, dropouts cannot be eliminated. When dropouts occur, they need to be statistically accounted for utilizing accepted imputation methods. In the recently released FDA draft analgesic guidance, a significant amount discussion was devoted to the appropriate statistical handling of missing data. Dr. Singla will provide a primer on accepted imputation techniques for acute and chronic analgesic studies.

View OnDemand: http://bit.ly/lotusreg14